US Stem Cell Inc Sustainability Reports
U.S. Stem Cell, Inc. is a biotechnology enterprise focused on the discovery, development, and commercialization of autologous cell therapies. Its products and protocols target the treatment of chronic cardiovascular, neurological, and orthopedic diseases through regenerative medicine.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300BYV51UWQXOKZ83
FIGI: BBG001SPW1R4
1 reports from 2016 to 2016